Kwality Pharmaceuticals Ltd (KPL) — Board Meeting | 31 August 2026

31 August 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Kwality Pharmaceuticals conducted its 43rd AGM on August 31, 2026 via video conference with 34 shareholders present.

💡 Investor Takeaway

Shareholders approved key governance and financial items, including financial statements and director reappointments.

Kwality Pharmaceuticals held its 43rd AGM on August 31, 2026 via video conference, with all directors present and 34 shareholders attending. The meeting approved the audited financial statements for FY2025-26, reappointed directors Aditya Arora and Anju Arora, appointed Swanith Kapoor as an independent director, and ratified cost auditors' remuneration. Shareholders participated through remote and e-voting channels, and the company secretary confirmed compliance with SEBI regulations.

📄 View Original Announcement (PDF)

📊 Stock Analysis — KPL ✨ Ask AI About This

About Kwality Pharmaceuticals Ltd (KPL)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹3,763.5 CrP/E: 46.4ROE: 24.4%ROCE: 25.4%

View full KPL stock details →

📡 Get AI alerts when KPL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track KPL — Free

💡 Ask AI about this filing

"When will the audited FY2025-26 financial results be publicly available?""What is the expected impact of appointing Swanith Kapoor on board governance?""How did shareholders vote on the director reappointments?"

Ask AI Free →

📊 More KPL filings

Announcement — 28 September 2026Kwality Pharmaceuticals Ltd announced that its trading window will close on October 1, 2026, remaini...
🟡 Voting Results — 2 September 2026Kwality Pharmaceuticals Limited held its 43rd Annual General Meeting on August 31, 2026, where share...
🟡 Board Meeting — 2 September 2026Kwality Pharmaceuticals announced at its August 31, 2026 AGM the regularization of Mr. Swanith Kapoo...
🟡 concall transcript — 30 June 2026Kwality Pharmaceuticals reported Q1 FY27 results with oncology revenue at 20% of total, down from 26...
🟡 concall transcript — 31 March 2026Kwality Pharmaceuticals reported FY26 revenue of INR503 crores (up 36% YoY) and PAT of INR67 crores ...

See all KPL filings →

🔥 Also filed on 31 August 2026

526159Nikhil Adhesives LtdAnnual Report VIDHIINGVidhi Specialty Food Ingredients LtdAnnual Report 544855Prima Innovation LtdAnnual Report TICLTwamev Construction & Infrastructure LtdAnnual Report TICLTwamev Construction & Infrastructure LtdAnnual Report TITilaknagar Industries LtdAnnual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when KPL files new disclosures

Track KPL filings, board meetings, and corporate actions. Free email alerts at 5 PM.